News

Evercyte to highlight immortalized cell potential in OOAC technology at SelectBIO Europe 2024 Congress

QMD Services: Erste In-vitro-Diagnostika-Zulassung in Rekordzeit

Effizientes Recyclingverfahren für seltene Erden durch Biolaugung und Bioakkumulation

MedUni Vienna: New insights on polymicrobial infections in chronic lung diseases

IMC: Effizientes Recyclingverfahren für seltene Erden durch Biolaugung und Bioakkumulation

Millioneninvestition in Pharmastandort Österreich

30 Millionen Investment für Pharmastandort

Basic research: Inhibition of epigenetic control enzymes in immune cells as a potential new starting point in cancer immunotherapy

Sandoz: EU-Kommission zu Gast bei Sandoz in Kundl: Kommissar Hahn besichtigt letzte große Penicillin-Hochburg Europas

Austrian Life Science Day 2024 mit Schwerpunkt zum Thema Gesundheitsdaten

LEPTON Pharmaceuticals LTD and TAmiRNA GmbH enhance their collaboration

TMW: Innovationen aus Medizintechnik und Life Sciences

MedUni Vienna: Prostate cancer: Protein identified to reduce tumour growth

VALANX Biotech Announces Promising Results in First In-Vivo Study of Novel Protein Conjugate Therapy

University Vienna: Uptake of tire wear additives by vegetables grown for human consumption

Roche: „Jetzt reden wir!“ Frauen fordern Umbruch im Gesundheitssystem

OGNT: World Prostate Cancer Day

MedUni Vienna: Heart: New heart valve prosthesis enables broader applicability

HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting

KLU: New Role of Tumor Suppressor STAT3β Discovered in Leukemia